Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies

Abstract

The plasma proteasome level is a potential new tool for the monitoring of patients with neoplastic disease. It is not correlated solely with cell lysis and may be involved in the pathophysiology of disease progression.